Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin
Open Access
- 12 June 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Archivum Immunologiae et Therapiae Experimentalis
- Vol. 68 (4) , 1-11
Abstract
T regulatory (Treg) cells play a critical role in the maintenance of self-tolerance, as well as in inhibition of inflammation and exaggerated immune response against exogenous antigens. They develop in the thymus (tTreg cells) but also may be generated at the peripheral tissues, including tumor microenvironment (pTreg cells), or induced in vitro in the presence of transforming growth factor (TGF)-β (iTreg cells). Since tTreg cells constitute a minor fraction of peripheral blood lymphocytes in physiological conditions, an alternative way to obtain high number of functional Treg cells for therapeutic purposes is their generation in vitro from conventional T cells. In our studies, we compared effectiveness of several pharmacological agents with suggested immunomodulatory effects on Treg development (rapamycin, prednisolone, inosine pranobex, glatiramer acetate, sodium butyrate, and atorvastatin) to optimize Treg-inducing protocols. All but one (atorvastatin) immunomodulators augmented induction of polyclonal Treg cells in cultures. They were effective both in increasing the number of CD4+CD25highFoxp3high cells and Foxp3 expression. Rapamycin and prednisolone were found the most effective. Both drugs prolonged also phenotypic stability of Treg cells and induced fully active Treg cells in a functional assay. In the assay, prednisolone appeared superior versus rapamycin. The results, on the one hand, may be helpful in planning optimal protocols for generation of Treg cells for clinical application and, on the other hand, shed some light on mechanisms of the immunomodulatory activity of some tested agents observed in vivo.Keywords
Funding Information
- Polish Ministry of Science and Higher Education (DI 2014 0192 44)
This publication has 50 references indexed in Scilit:
- Comparing the efficacy of disease-modifying therapies in multiple sclerosisMultiple Sclerosis and Related Disorders, 2017
- Regulatory T Cells in Allergy and AsthmaFrontiers in Pediatrics, 2017
- A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyCytotherapy, 2016
- Regulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus ErythematosusPLOS ONE, 2015
- Glucocorticoids decrease Treg cell numbers in lungs of allergic miceEuropean Journal of Pharmacology, 2015
- Statins as Modulators of Regulatory T-Cell BiologyMediators of Inflammation, 2013
- Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stabilityEuropean Journal of Immunology, 2012
- Inducing and expanding regulatory T cell populations by foreign antigenNature Immunology, 2005
- Induction of CD4+CD25+regulatory T cells by copolymer-I through activation of transcription factor Foxp3Proceedings of the National Academy of Sciences, 2005
- Generation Ex Vivo of TGF-β-Producing Regulatory T Cells from CD4+CD25− PrecursorsThe Journal of Immunology, 2002